Charts

HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Good morning and thank you for joining the HOOKIPA Pharma Fourth Quarter and Full Year 2022 Earnings and 2022 Outlook Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a […]

HOOKIPA Pharma ( NASDAQ:HOOK ) Full Year 2022 Results Key Financial Results Revenue: US$14.2m (down 23% from FY 2021...

According to data from Benzinga Pro, during Q4, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $7.83 million. Despite a 32.65% ...

Q4 2022 HOOKIPA Pharma Inc Earnings Call

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share ...

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of 5.56% and 41.25%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Data from Phase 2 study of HB-200 in combination with pembrolizumab in head and neck cancers expected in 2Q 2023 Phase 1 HB-300 trial in metastatic castration-resistant prostate cancer open for enrollment KRAS program (HB-700) achieved its first milestone payment in the Roche collaboration in February 2023; plan to submit IND in 1H 2024 Strengthened cash position of $113.4 million at year-end; additional $15.0 million cash inflow from collaboration milestones in early 2023 NEW YORK and VIENNA, M

HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Wednesday, 2023-03-15. Here's what investors need to ...

NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023. “Terry is an immensely valuable addition to our Board given her experience in business strategy, broad financial transactions and business development, and we

Gainers Molecular Templates (NASDAQ:MTEM) shares rose 31.9% to $0.62 during Friday's pre-market session. The company's market cap ...

NEW YORK and VIENNA, March 08, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release fourth quarter and full year 2022 financial results before the market opens on Wednesday, March 15, 2023. The Company will host a live conference call and webcast at 8:30 AM ET to discuss its financial results and provide a corporate update. Conference Call &

NEW YORK and VIENNA, Austria, Feb. 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced that it has achieved a $10 million non-dilutive milestone payment under its collaboration agreement with Roche to develop HB-700, a novel arenaviral immunotherapy for KRAS-mutated cancers. The success-based milestone payment reflects the start of the HB-700 manufacturing pro

NEW YORK and VIENNA, Austria, Feb. 07, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the company will participate in the virtual SVB Securities Global Biopharma Conference, February 14 - 16, 2023. Corporate Presentation: Tuesday, February 14, 2023 at 10:00 AM EST The webcast of the presentation will be available within the Investors & Media section o

Gainers Calyxt (NASDAQ:CLXT) stock increased by 140.3% to $0.45 during Tuesday's pre-market session. The company's market cap stands at ...

NEW YORK and VIENNA, Austria, Jan. 04, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced that it has achieved a $5 million non-dilutive milestone payment under its collaboration agreement with Gilead Sciences, Inc. HOOKIPA completed and delivered a regulatory support package for Gilead’s Phase 1 clinical trial of an investigational therapeutic vaccine for chroni

In this article, we discuss the 12 penny stocks with the biggest upside. If you want to read about some more penny stocks with the biggest upside, go directly to 5 Penny Stocks With Biggest Upside. Even though the United States economy has been rattled by recession fears in the past few months, there are […]

NEW YORK and VIENNA, Austria, Dec. 15, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today the promotion of Katia Schlienger, M.D., Ph.D., to Chief Medical Officer and the appointment of Malte Peters, M.D., to its Board of Directors, both effective January 1, 2023. “Katia has had a major impact on HOOKIPA’s clinical development strategy and execution in immuno-

NEW YORK and VIENNA, Austria, Nov. 30, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the company will participate virtually in investor meetings and panel discussions at The JMP Securities Hematology and Oncology Summit, December 6 - 7, 2022. About HOOKIPA HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company focused on dev

Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday's after-market session. The market value of ...

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares rose 55.1% to $0.1578 in pre-market trading after dipping around 48% on Tuesday. ...

HOOKIPA Pharma Inc. ( NASDAQ:HOOK ) shareholders will have a reason to smile today, with the analysts making...

HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of -4.17% and 31.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Major oncology collaboration and license agreement secured with Roche to develop HB-700 for KRAS-mutated cancers and an additional undisclosed oncology candidateInvestigational New Drug Application for HB-300 for the treatment of metastatic castration-resistant prostate cancer accepted by the FDAEnrollment in the Phase 2 study of HB-200 in combination with pembrolizumab is ongoing; next data update expected in the first half of 2023 NEW YORK and VIENNA, Austria, Nov. 14, 2022 (GLOBE NEWSWIRE) --

Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 9-10, 2022.

AVEO (AVEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEW YORK and VIENNA, Austria, Nov. 07, 2022 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced it will release its third quarter 2022 financial results and Company update before the market opens on Monday, November 14, 2022. The company will not be conducting a conference call in conjunction with this earnings release. About HOOKIPAHOOKIPA Pharma Inc. (NASDAQ: HOOK) i

HOOKIPA Pharma Inc. (HOOK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the pace with technology.

On Thursday, shares of HOOKIPA Pharma Inc. (NASDAQ: HOOK) experienced volatile short activity. After the activity, the stock price went ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Indonesia Energy (INDO) stock is climbing higher on Thursday after the company announced the discovery of oil in one of its new wells. The post Why Is Indonesia Energy (INDO) Stock Up Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF). The post Why Is Hookipa (HOOK) Stock Up 26% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value ...

Gainers Homology Medicines (NASDAQ:FIXX) shares rose 11.3% to $3.16 during Monday's pre-market session. The market ...

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what ...

The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK)Investigational New Drug (IND) ...

Gainers Quotient (NASDAQ:QTNT) shares rose 34.6% to $0.5 during Wednesday's pre-market session. The market value of ...

According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% ...

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what ...

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at ...

HOOKIPA Pharma Inc(NASDAQ: HOOK) hasannounced preclinical datademonstrating potent T cell responses, combination use ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Aeglea Shares Additional ...

Biotech stocks managed to carve out modest gains for the week endingApril 8, defying the broader market weakness. The defensive ...

Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Value ETF (IWN), we found that the implied analyst target price for the ETF based upon its underlying holdings is $198.72 per unit.

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 25.0% to $2.15 during Friday's regular session. HOOKIPA ...

Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Novartis Announces FDA ...

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 ...

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • ...

HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to ...

Biotech stocks rebounded along with the broader market in the week endingMarch 18, as risk appetite returned. Multiple conference ...

HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to ...

Looking back to 2 days ago, HOOKIPA Pharma Inc (HOOK) priced a 21,700,000 share secondary stock offering at $2.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial ...

Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 ...

Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine, trader! It's time to start off another day of trading with the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on ...

Gainers Organogenesis Holdings (NASDAQ:ORGO) stock rose 15.9% to $8.39 during Tuesday's after-market session. Today's trading volume ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell 2000 Growth ETF (IWO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $368.42 per unit.

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur ...

Gainers Sky Harbour Group Corporation (NYSE: SKYH) shares jumped 48.4% to close at $10.09 on Friday. RISE Education Cayman Ltd ...